Dithymoquinone Analogues as Potential Candidate(s) for Neurological Manifestation Associated with COVID-19: A Therapeutic Strategy for Neuro-COVID
The COVID-19 era has prompted several researchers to search for a linkage between COVID-19 and its associated neurological manifestation. Toll-like receptor 4 (TLR-4) acts as one such connecting link. spike protein of SARS-CoV-2 can bind either to ACE-2 receptors or to TLR-4 receptors, leading to ag...
Main Authors: | Afrasim Moin, Bader Huwaimel, Ahmed Alobaida, Mohammed Khaled Bin Break, Danish Iqbal, Rahamat Unissa, Qazi Mohammad Sajid Jamal, Talib Hussain, Dinesh C. Sharma, Syed Mohd Danish Rizvi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/7/1076 |
Similar Items
-
Computational Identification of Dithymoquinone as a Potential Inhibitor of Myostatin and Regulator of Muscle Mass
by: Syed Sayeed Ahmad, et al.
Published: (2021-09-01) -
Oleuropein as a Potent Compound against Neurological Complications Linked with COVID-19: A Computational Biology Approach
by: Talib Hussain, et al.
Published: (2022-06-01) -
A case of neuro retinitis in association with COVID-19
by: Asmita Mahajan, et al.
Published: (2022-01-01) -
Neuro-ophthalmic presentation of COVID-19 disease: A case report
by: Venkatram Katti, et al.
Published: (2021-01-01) -
Characteristics and operation outcomes of neuro-oncology patients after COVID-19 pandemic — A case series
by: Yichun Zou, et al.
Published: (2021-09-01)